Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Return on Equity %

Adverum Biotechnlgs Return on Equity % Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Return on Equity % from 2014 to 2020.
  • Adverum Biotechnlgs Return on Equity % for the quarter ending June 06, 2020 was -39.83 a 5.32% decrease of -2.12 year over year
  • Adverum Biotechnlgs Return on Equity % for the last 12 months ending June 06, 2020 was -37.87 a 14.86% decrease of -5.63 year over year
  • Adverum Biotechnlgs Annual Return on Equity % for 2019 was -34.29 a -9.97% increase of 3.42 from 2018
  • Adverum Biotechnlgs Annual Return on Equity % for 2018 was -37.71 a 25.48% decrease of -9.61 from 2017
  • Adverum Biotechnlgs Annual Return on Equity % for 2017 was -28.10 a -72.92% increase of 20.49 from 2016
Other Margins & Efficiency Metrics:
  • Adverum Biotechnlgs EBITDA Margin for the quarter ending March 03, 2013 was $-13m
  • Adverum Biotechnlgs Return on Capital % for the quarter ending September 09, 2018 was -20.57 a -10.43% increase of 2.15 year over year
View Chart On Koyfin

Quarterly ADVM Return on Equity % Data

06/2020-39.83
03/2020-38.26
12/2019-44.64
09/2019-37.71
06/2019-32.70
03/2019-29.77
12/2018-30.06
09/2018-37.34
06/2018-31.38
03/2018-31.99

Annual ADVM Return on Equity % Data

2019-34.29
2018-37.71
2017-28.10
2016-48.59
2015-23.60
2014-34.02
2013969.85